Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology

J Allergy Clin Immunol. 2005 Jun;115(6):1249-53. doi: 10.1016/j.jaci.2005.04.006.
No abstract available

Publication types

  • Comparative Study
  • Guideline
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adolescent
  • Adult
  • Age Factors
  • Animals
  • Calcineurin Inhibitors*
  • Child
  • Dermatitis, Atopic / drug therapy*
  • Dose-Response Relationship, Drug
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use*
  • Lymphoma / chemically induced
  • Mice
  • Neoplasms / epidemiology
  • Neoplasms, Experimental / chemically induced
  • Product Surveillance, Postmarketing
  • Tacrolimus / administration & dosage
  • Tacrolimus / adverse effects*
  • Tacrolimus / analogs & derivatives*
  • Tacrolimus / therapeutic use*

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • pimecrolimus
  • Tacrolimus